Newsroom | 9826 results

Sorted by: Latest

Mental Health
-

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences: TD Cowen's 46th Annual Health Care Conference Fireside Chat: Monday, March 2, 2026 at 11:10 a.m. Eastern Time in Boston, MA The Citizens Life Sciences Conference Fireside Chat: Wednesday, March 11, 2026 at 1:05 p.m. Eastern Time in Miami Beach, FL Live webcasts will be accessible on the company’s website, acadia.com, under the investors section...
-

Bradford Health Services Announces Expansion Into Midwest With Acquisition of Parkdale Center, Expanding Specialized Treatment for Professionals

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Bradford Health Services (Bradford), a nationally recognized substance use disorder treatment provider, today announced the acquisition of Parkdale Center, a leading addiction treatment provider in Chesterton, Indiana. Parkdale Center is widely renowned for its specialized Professionals Program serving healthcare providers, attorneys, executives, aviation professionals, first responders, and other licensed professionals seeking confidential treatment and long-...
-

Serenity Mental Health Centers Expands Mental Health Services in Dallas

DALLAS--(BUSINESS WIRE)--Serenity Mental Health Centers, a leader in psychiatric care and one of the fastest growing mental health providers in the nation, is elevating mental health services in Dallas by providing advanced, patient-centered treatment options at its clinics in Frisco, Las Colinas, Fort Worth, Southlake, Arlington, and University Park. Serenity’s board-certified psychiatrists and psychiatric mental health nurse practitioners provide full-spectrum mental health services tailored...
-

Acadia Healthcare to Participate in March Investor Conferences

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in three investor conferences in March. On Monday, March 2, 2026, the Company will participate in the Raymond James & Associates’ 47th Annual Institutional Investors Conference, being held March 1-4, 2026, in Orlando, Florida. The Company’s presentation/fireside chat will begin at 11:35 a.m. Eastern Time/10:35 a.m. Central Time. On Monday, March 9, 2026, the Com...
-

Seaport Therapeutics Presents New Meta-Analysis Examining the Impact of Clinical Trial Design Factors on Placebo Response in Generalized Anxiety Disorder Trials

BOSTON--(BUSINESS WIRE)--Seaport presents new meta-analysis examining the impact of clinical trial design factors on placebo response in generalized anxiety disorder trials...
-

Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, February 26, 2026 to report financial results for the full year ended December 31, 2025, and discuss recent business updates. Listeners...
-

Groundbreaking Clinical Study Reveals Promising Evidence for VIVAZEN®’s Kratom Extracts

PHOENIX--(BUSINESS WIRE)--VIVAZEN® proudly announces the results of a pioneering 28-day clinical study evaluating the safety and tolerability of its proprietary kratom extracts. The findings, presented by Dr. Jenelle Patterson of Gowling WLG, at the University of Florida Fifth Scientific Kratom Symposium, reinforce VIVAZEN®’s dedication to advancing knowledge in botanical wellness through rigorous scientific research. The study assessed the effects of VIVAZEN®’s proprietary kratom extract on ad...
-

Chronilogix Integrates with Balance for Life to Expand AI-Driven Behavioral Health and Chronic Care Support

PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Chronilogix, a digital health company delivering AI-powered coaching for behavioral health and chronic condition management, announced today a new integration with Balance for Life, a wellness and mental health application serving health plan members and consumers. The integration embeds Chronilogix’s AI coaching technology directly into the Balance for Life platform, providing users with on-demand behavioral health support for depression, anxiety and...
-

Unified Women’s Healthcare Responds to Rising Demand for Menopause Care

TAMPA, Fla.--(BUSINESS WIRE)--Unified Women’s Healthcare (Unified), in partnership with its OBGYN affiliates, is expanding access to perimenopause and menopause care nationwide through Unified for You, its patient resource platform and corresponding awareness campaign, which initially launched in Florida earlier this month. Recent data shows many women experience years of untreated menopause-related conditions before receiving appropriate care, highlighting the importance of timely counseling,...
-

Doc.com Expands U.S. Rollout with Florida Launch, Advancing AI-Powered Blockchain Secured Healthcare Access

NEW YORK--(BUSINESS WIRE)--Doc.com, the pioneering healthcare technology company redefining access to care through artificial intelligence and blockchain integration, today announced the launch of its telemedicine platform in Florida as part of its ongoing United States expansion. The Florida rollout marks a significant milestone in the company’s multi-phase national growth strategy. Through a seamless mobile experience, Florida residents can now connect with licensed healthcare professionals w...